Association Between Vitamin D Levels With Mdr-Tb Patients With Household Contacts And Healthy People As Comparison
DOI:
https://doi.org/10.29103/micohedmed.v1i1.20Keywords:
: multidrug resistant tuberculosisAbstract
AbstractBackground: The high incidence of pulmonary tuberculosis (TB) progressing into multidrugresistant TB (MDR-TB) has become a serious concern and caused a high mortality rate. The incidence of MDR-TB was 3.3% of new cases and 20% of cases of recurrent treatment. Low levels of vitamin D is a predisposing factor of MDR-TB, and family members in contact with the patient also show risk of infection. Currently, there is no study that compares vitamin D levels between MDR-TB patients and their household contact.
Method: This is a case control study, with the number of samples of each group (MDR-TB patients, household contact, healthy controls) 40 subjects, respectively. Each member of each group were checked for vitamin D levels using enzyme-linked immunosorbent assay (ELISA) technique.
Result: Mean levels of vitamin D in MDR-TB patients are 32.21, contact families 31.7 and healthy controls 26.86. There is a significant relationship between vitamin D levels and MDR-TB incidence (p=0.006).
Conclusion : There was no significant association between vitamin D deficiency level with MDRTB. Vitamin D insufficiency was a protective factor for MDR-TB than in healthy control.
References
Alimudin Z, Raviglione M, Hafner R, Von Reyn CF, (2013) Tuberculosis N Engl J Med ; 368:745-55.
Edem VF, Ige O, Arinola OG. 2016. Plasma Vitamin and Essential Trace Elements in Multi-Drug Resistant Tuberculosis Patients Before and During Chemotheraphy.Egyp J Chest Dis Tuberc (2016)
Howthorne GH,Thickett DR. (2011)
Vitamin D and Tuberculosis.College of Clinical and Exprerimental Medicine, University of Birmingham-united
Kingdom, 185-187
Iftikhar R, Kamran SM, Qadir A, Haider E,
Usman HB. 2013. Vitamin D Deficiency in Patients with Tuberculosis. J of the College of Physicians and Surgeons Pakistan. Vol 23 (11): 780-3
Joshi L, Ponnana M, Penmetsa SR, Nallari P, Valluri V, Gaddam S. (2013) Serum
Vitamin D Levels and VDR
Polymorphisms (BsmI and FokI) in Patients and their Household Contacts Susceptible to Tuberculosis. John Wiley & Sons Ltd. Human
Immunology.
Kementrian Kesehatan Republik Indonesia. (2014) Petunjuk Teknis Manajemen Terpadu Pengendalian
Tuberkulosis Resisten Obat. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Jakarta.
Lagunova Z, Porojnicu AL, Lindberg F, Hexeberg S, Moan J.(2009) The Dependency of Vitamin D Status on Body Mass Index, Gender, Age and
Season. Anticancer Research 29:3713-
Li X. X, Lu W, Zu R. Q, Zhu L. M, Yang H. T, et al (2015) Comparing Risk Factor for Primary Multidrug Resistant
Tuberculosis and Primary DrugSusceptible Tuberculosis in Jiangsu Province, China : A Matched-Pairs Case-Control Study. American Society of Tropical Medicine and Hygiene.
Margulies SL, Kurian D, Elliott M, Han Z. Vitamin D Deficiency in Patients with Intestinal Malabsorption Syndromesthink in and Outside The Gut. Journal of Digestive Diseases. 2015; 16: 617633.
Park H. O, Kim S. H, Moon S. H, Byun J. H, Kim J. W et al. (2016) Association Between Body Mass Index and Sputum Culture Conversion among South Korean Patients with Multidrug
Resistant Tuberculosis in a
Tuberculosis Referral Hospital. Infect Chemother 2016;48(4):317
Putri F. A, Burhan E, Nawas A, Soepandi P. Z, Sutoyo D. K et al (2014). Body Mass Index Predictive of Sputum Culture Conversion among MDR-TB Patient in Indonesia. RS Persahabatan Jakarta. The Int J Tuberculosis and Lung Disease
Raja Alamelu. (2004) Immunology of tuberculosis. Indian J Med Res 120: 213-232.
Rathored J, Sharma SK, Singh B, Banavaliker JM, Sreenivas V, Srivastana AK et al (2012) Risk and outcome of multidrug-resistant tuberculosis : vitamin D receptor polymorphisme and serum 25 (OH)D. Int J Tuberc Lung Dis.Nov 16
(11):1522-8
Saragih JP, Sinaga B, Amir Z. 2015. Hubungan Kadar Vitamin D dalam Darah dengan Kejadian Tuberkulosis Paru. J Respir Indo Vol. 35
Saltini, C. (2006). Chemotherapy and Diagnosis of Tuberculosis. Respir Med, 100(12): 2085-2097.
World Health Organization (2015) Global tuberculosis report. Geneva,
Switzerland.
World Health Organization (2015) Multidrug-resistant Tuberculosis (TBMDR).Geneva, Switzerland.
Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM, Tangprica V. (2010) Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr. 92: 603-611.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nina Herlina, Bintang Yinke Magdalena Sinaga, Parluhutan Siagian, Erna Mutiara
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
n order for Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) to publish and disseminate research articles, we need non-exclusive publishing rights (transfered from author(s) to publisher). This is determined by a publishing agreement between the Author(s) and Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED). This agreement deals with the transfer or license of the copyright of publishing to Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED), while Authors still retain significant rights to use and share their own published articles. Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.
As a proceeding Author, you have rights for a large range of uses of your article, including use by your employing institute or company. These Author rights can be exercised without the need to obtain specific permission. Authors publishing in Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) proceedings have wide rights to use their works for teaching and scholarly purposes without needing to seek permission, including:
- use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees;
- use for internal training by author's company;
- distribution to colleagues for their reseearch use;
- use in a subsequent compilation of the author's works;
- inclusion in a thesis or dissertation;
- reuse of portions or extracts from the article in other works (with full acknowledgement of final article);
- preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article);
- voluntary posting on open web sites operated by author or author’s institution for scholarly purposes,
(but it should follow the open access license of Creative Common CC-by-SA License).
Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).
